½ÃÀ庸°í¼­
»óǰÄÚµå
1594664

¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå : À¯Çü, Èí¼ö ´É·Â, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Ophthalmic Sutures Market by Type (Natural, Synthetic), Absorption Capacity (Absorbable Sutures, Non-Absorbable Sutures), Application, End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀº 2023³â 3¾ï 9,747¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 4¾ï 2,607¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 7.59% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 6¾ï 6,337¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È°ú¿ë ºÀÇÕ»ç´Â ¾È°ú ¼ºÇü ¼ö¼ú¿¡¼­ Àý°³¿Í »óó¸¦ ºÀÇÕÇϰí Ä¡À¯¸¦ ÃËÁøÇϰí ÇØºÎÇÐÀû ¹«°á¼ºÀ» º¸ÀåÇϱâ À§ÇØ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á¿ë ½ÇÀÔ´Ï´Ù. ¾È°ú¿ë ºÀÇÕ»çÀÇ ¹üÀ§´Â ¼ö¼ú ÈÄ ´«ÀÇ ¼¶¼¼ÇÑ ±¸Á¶¸¦ À¯ÁöÇÏ´Â µ¥ ÇÊ¿äÇÑ °Í, ¹é³»Àå Á¦°Å, °¢¸· À̽Ä, ¸Á¸· ¹Ú¸® º¹±¸¿Í °°Àº ´Ù¾çÇÑ ¾È°ú ¼ºÇü ¼ö¼ú¿¡ »ç¿ëµÇ´Â °Í, º´¿ø ¹× Àü¹® ¾È°ú Ŭ¸®´ÐÀ» Æ÷ÇÔÇÑ ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ÃÖÁ¾ ¿ëµµ¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀº ¾È°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÇÕ¼º ºÀÇÕ»ç ¹× »ýºÐÇØ¼º ºÀÇÕ»ç¿Í °°Àº ¼ö¼ú ±â¼ú ¹× Àç·áÀÇ ±â¼ú ¹ßÀü¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­´Â ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¦Á¶¾÷üµé¿¡°Ô »ç¾÷ È®ÀåÀÇ ÀáÀçÀû ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ ¾ÈÀü°ú ¼ö¼ú °á°ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ °íǰÁú ºÀÇջ翡 ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇÑ »ýºÐÇØ¼º ºÀÇÕ»ç ¹× Ç×±Õ ºÀÇÕ»ç ±â¼ú¿¡ ´ëÇÑ Çõ½ÅÀÇ ±âȸ°¡ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª °í±Þ ºÀÇÕ»ç¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¼÷·ÃµÈ ¾È°ú ÀÇ»ç ºÎÁ· µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ¾î ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¢ÂøÁ¦³ª ½Ç¶õÆ® µî ´ëü °¡´ÉÇÑ »óó ºÀÇÕ ¹æ¹ýÀÌ µîÀåÇϰí ÀÖ´Â °Íµµ °æÀï ¾Ð·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ ÃÊÁ¡Àº ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µÀ» À§ÇÑ ¼¾¼­°¡ ³»ÀåµÈ ½º¸¶Æ® ºÀÇÕ»ç °³¹ß, ºÀÇÕ»ç ¼ÒÀçÀÇ °³¼±À¸·Î Á¤È®µµ¿Í °­µµ Çâ»ó, »óó Ä¡À¯¸¦ ÃËÁøÇÏ´Â ¼ºÀåÀÎÀÚ Àü´Þ ½Ã½ºÅÛÀÇ ÅëÇÕ µîÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, Á¦Ç° Â÷º°È­¿Í ºñ¿ë È¿À²¼ºÀÌ ½ÃÀå Á¡À¯À²À» È®º¸ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °¢ ¾÷üµéÀº Á¦Ç° Á¦°ø°ú ½ÃÀå ÁøÀÔÀ» °­È­Çϱâ À§ÇØ ¿¬±¸°³¹ß°ú Àü·«Àû Á¦ÈÞ¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ȯÀÚ Á᫐ ¼Ö·ç¼ÇÀ» Ȱ¿ëÇÏ°í °ø±Þ¸ÁÀ» ÃÖÀûÈ­ÇÔÀ¸·Î½á ÀÌÇØ°ü°èÀÚµéÀº ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ¿ä±¸¿¡ ´õ Àß ´ëÀÀÇϰí Áö¼Ó°¡´ÉÇÑ ¼ºÀåÀ» ÃËÁøÇÏ¸ç °¡Ä¡ Áß½ÉÀÇ ÀÇ·á ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 3¾ï 9,747¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 4¾ï 2,607¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 6¾ï 6,337¸¸ ´Þ·¯
CAGR(%) 7.59%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • °¢Á¾ ¾ÈÁúȯ ¹× ½Ã·ÂÀúÇÏ ¹ß»ý·ü Áõ°¡
    • ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í ¾È°ú ÁúȯÀ¸·Î À̾îÁö´Â ´ç´¢º´ À¯º´·üÀÇ Áõ°¡
    • ÃÖ¼Òħ½À ¼ö¼ú ¹× Èí¼ö¼º ºÀÇÕ»ç äÅÃ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¾È°ú¿ë ºÀÇÕ»ç¿Í °ü·ÃµÈ ¼ö¼ú ÈÄ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • ¾È°ú¿ë ºÀÇÕ»çÀÇ ±â¼ú ¹ßÀü
    • ¿Ü·¡ ¼ö¼ú¼¾ÅÍ ¹× ´çÀÏ ¼ö¼ú Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ ¼÷·ÃµÈ ¾È°ú ÀÇ»ç ºÎÁ·

Porter's Five Forces : ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

¾È°ú¿ë ºÀÇÕ»ç ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå : À¯Çüº°

  • õ¿¬
  • ÇÕ¼º

Á¦7Àå ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå : Èí¼ö ´É·Âº°

  • Èí¼ö¼º ºÀÇÕ»ç
  • ºñÈí¼ö¼º ºÀÇÕ»ç

Á¦8Àå ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå : ¿ëµµº°

  • ¹é³»Àå ¼ö¼ú
  • °¢¸·ÀÌ½Ä ¼ö¼ú
  • ȫä ÀýÁ¦ ¼ö¼ú
  • ´« ¼ºÇü¿Ü°ú
  • À¯¸®Ã¼ÀýÁ¦ ¼ö¼ú

Á¦9Àå ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾È°ú¿ë ºÀÇÕ»ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Alcon Inc.
  • Asset Medical Sarl
  • Aurolab
  • B Braun Melsungen AG
  • Conmed Corporation
  • DemeTech Corporation
  • Integra LifeSciences Corporation
  • Internacional Farmaceutica S.A.
  • Johnson & Johnson
  • Lotus Surgicals Pvt Ltd.
  • MANI, Inc.
  • Medtronic PLC
  • Mellon Medical B.V.
  • Peters Surgical
  • Smith & Nephew PLC
  • Teleflex Incorporated
  • Unisur Lifecare Pvt. Ltd.
ksm 24.11.28

The Ophthalmic Sutures Market was valued at USD 397.47 million in 2023, expected to reach USD 426.07 million in 2024, and is projected to grow at a CAGR of 7.59%, to USD 663.37 million by 2030.

Ophthalmic sutures are specialized medical threads used in ophthalmic surgeries to close incisions or wounds, promoting healing and ensuring anatomical integrity. The scope of ophthalmic sutures encompasses their necessity in maintaining the delicate structure of the eye post-surgery, applications in various eye procedures such as cataract removal, corneal transplantation, and repair of retinal detachments, and end-use by healthcare providers including hospitals and specialized eye clinics. The market for ophthalmic sutures is significantly influenced by the rising prevalence of eye disorders, an increasing geriatric population, and technological advancements in surgical techniques and materials, such as synthetic and biodegradable sutures. Growing investments in healthcare infrastructure, particularly in emerging markets, present potential opportunities for manufacturers to expand their footprint. Enhanced focus on patient safety and surgery outcomes boosts the demand for high-quality sutures, highlighting an opportunity for innovation in biodegradable and antimicrobial suture technologies to reduce postoperative complications. However, the market faces challenges such as high costs associated with advanced sutures, stringent regulatory requirements, and a shortage of skilled ophthalmic surgeons, which can hinder growth. Furthermore, the presence of alternative wound closure methods like adhesives and sealants adds competitive pressure. Innovations could focus on developing smart sutures with embedded sensors for postoperative monitoring, improving suture materials for enhanced precision and strength, and incorporating growth factor delivery systems to facilitate wound healing. The ophthalmic suture market is characterized by fierce competition, where product differentiation and cost-effectiveness play crucial roles in gaining market share. Companies need to focus on R&D and strategic partnerships to enhance their product offerings and market reach. By leveraging patient-centric solutions and optimizing the supply chain, stakeholders can better address the needs of the ophthalmic sutures market, fostering sustainable growth and providing value-driven healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 397.47 million
Estimated Year [2024] USD 426.07 million
Forecast Year [2030] USD 663.37 million
CAGR (%) 7.59%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Sutures Market

The Ophthalmic Sutures Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of various eye diseases and vision loss
    • Rising elderly population and rising prevalence of diabetes leading to ophthalmic diseases
    • Adoption of minimally invasive surgeries and absorbable sutures
  • Market Restraints
    • Postoperative complexities associated with ophthalmic sutures
  • Market Opportunities
    • Technological advancement in ophthalmic sutures
    • Increasing number of ambulatory surgical centers and single-day surgeries
  • Market Challenges
    • Limited trained and skilled ophthalmologists

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Sutures Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Sutures Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Sutures Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Sutures Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Sutures Market

A detailed market share analysis in the Ophthalmic Sutures Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Sutures Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Sutures Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Sutures Market

A strategic analysis of the Ophthalmic Sutures Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Sutures Market, highlighting leading vendors and their innovative profiles. These include Alcon Inc., Asset Medical Sarl, Aurolab, B Braun Melsungen AG, Conmed Corporation, DemeTech Corporation, Integra LifeSciences Corporation, Internacional Farmaceutica S.A., Johnson & Johnson, Lotus Surgicals Pvt Ltd., MANI, Inc., Medtronic PLC, Mellon Medical B.V., Peters Surgical, Smith & Nephew PLC, Teleflex Incorporated, and Unisur Lifecare Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Sutures Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Natural and Synthetic.
  • Based on Absorption Capacity, market is studied across Absorbable Sutures and Non-Absorbable Sutures.
  • Based on Application, market is studied across Cataract Surgery, Corneal Transplantation Surgery, Iridectomy Surgery, Oculoplastic Surgery, and Vitrectomy Surgery.
  • Based on End-user, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of various eye diseases and vision loss
      • 5.1.1.2. Rising elderly population and rising prevalence of diabetes leading to ophthalmic diseases
      • 5.1.1.3. Adoption of minimally invasive surgeries and absorbable sutures
    • 5.1.2. Restraints
      • 5.1.2.1. Postoperative complexities associated with ophthalmic sutures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in ophthalmic sutures
      • 5.1.3.2. Increasing number of ambulatory surgical centers and single-day surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Limited trained and skilled ophthalmologists
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmic Sutures Market, by Type

  • 6.1. Introduction
  • 6.2. Natural
  • 6.3. Synthetic

7. Ophthalmic Sutures Market, by Absorption Capacity

  • 7.1. Introduction
  • 7.2. Absorbable Sutures
  • 7.3. Non-Absorbable Sutures

8. Ophthalmic Sutures Market, by Application

  • 8.1. Introduction
  • 8.2. Cataract Surgery
  • 8.3. Corneal Transplantation Surgery
  • 8.4. Iridectomy Surgery
  • 8.5. Oculoplastic Surgery
  • 8.6. Vitrectomy Surgery

9. Ophthalmic Sutures Market, by End-user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals

10. Americas Ophthalmic Sutures Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Ophthalmic Sutures Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Sutures Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcon Inc.
  • 2. Asset Medical Sarl
  • 3. Aurolab
  • 4. B Braun Melsungen AG
  • 5. Conmed Corporation
  • 6. DemeTech Corporation
  • 7. Integra LifeSciences Corporation
  • 8. Internacional Farmaceutica S.A.
  • 9. Johnson & Johnson
  • 10. Lotus Surgicals Pvt Ltd.
  • 11. MANI, Inc.
  • 12. Medtronic PLC
  • 13. Mellon Medical B.V.
  • 14. Peters Surgical
  • 15. Smith & Nephew PLC
  • 16. Teleflex Incorporated
  • 17. Unisur Lifecare Pvt. Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦